Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics, dosimetry, tolerance, tumor
detection rate of 68Ga-PSMA-33 in patient with Prostate Cancer (PCa).
Phase:
N/A
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University